Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.18M Sell
77,600
-10,927
-12% -$1.26M 0.01% 575
2026
Q1
$10.6M Buy
+88,527
New +$11.6M 0.01% 497
2025
Q3
$4.95M Buy
+33,579
New +$4.66M 0.03% 403

Other funds holding XYL

CIBC Bancorp USA's XYL Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Xylem (XYL) stake by 12% in Q2 2026, selling an estimated $1.26M and leaving 77,600 shares worth $9.18M. The position accounts for 0.01% of the portfolio, ranked #575.

CIBC Bancorp USA first reported a position in XYL in Q3 2025 and has held it in 3 quarters since. The position peaked at $10.6M in Q1 2026. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • CIBC Bancorp USA held 77,600 shares of Xylem worth $9.18M as of Q2 2026.
  • CIBC Bancorp USA sold 10,927 Xylem shares in Q2 2026, an estimated $1.26M.
  • Xylem made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #575 holding.
  • CIBC Bancorp USA first reported a position in Xylem in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Xylem position peaked at $10.6M in Q1 2026.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.